367 related articles for article (PubMed ID: 25724737)
1. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
3. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 70 selectively mediates the degradation of cytosolic PrPs and restores the cytosolic PrP-induced cytotoxicity via a molecular interaction.
Zhang J; Wang K; Guo Y; Shi Q; Tian C; Chen C; Gao C; Zhang BY; Dong XP
Virol J; 2012 Dec; 9():303. PubMed ID: 23216755
[TBL] [Abstract][Full Text] [Related]
5. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
7. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
Atarashi R; Sim VL; Nishida N; Caughey B; Katamine S
J Virol; 2006 Aug; 80(16):7854-62. PubMed ID: 16873242
[TBL] [Abstract][Full Text] [Related]
8. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
9. Prions in skeletal muscle.
Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
[TBL] [Abstract][Full Text] [Related]
10. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
11. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
13. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
[TBL] [Abstract][Full Text] [Related]
15. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
16. Enhanced M-CSF/CSF1R Signaling Closely Associates with PrP
Xia Y; Chen C; Chen J; Hu C; Yang W; Wang L; Liu L; Gao LP; Wu YZ; Chen DD; Shi Q; Chen ZB; Dong XP
Mol Neurobiol; 2022 Oct; 59(10):6534-6551. PubMed ID: 35970974
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
18. Copaxone interferes with the PrP Sc-GAG interaction.
Engelstein R; Ovadia H; Gabizon R
Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008
[TBL] [Abstract][Full Text] [Related]
19. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
20. FBXW7-Induced MTOR Degradation Forces Autophagy to Counteract Persistent Prion Infection.
Xu Y; Tian C; Sun J; Zhang J; Ren K; Fan XY; Wang K; Wang H; Yan YE; Chen C; Shi Q; Dong XP
Mol Neurobiol; 2016 Jan; 53(1):706-719. PubMed ID: 25579381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
